ProKidney Corp.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving ProKidney Corp. now
Current reporting with the operating signal separated from the noise.
PROK|ProKidney Corp|Price:1.540|Chg%:-0.040
The story matters when it changes ProKidney Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ProKidney Corp (PROK) Financial Health: Profitability & Balance Sheet Analysis
Investors are testing whether ProKidney Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.ProKidney Corp (PROK) Institutional Confidence
The story matters when it changes ProKidney Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest PROK filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
ProKidney Corp., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →